Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (175)	12/16/1997 8:38:00 AM
From: andy harrison	Respond to of 507

Obviously, SSI who makes NVX's D & T components is a superior manufacturer and is able to extract all formaldehyde in the purification process so your comment is meaningless. From what we have heard, the NVX injection doesnt even sting upon injection because there is no formaldehyde in the vaccine. If there was, NVX would be showing the same problems that the other makers are encountering with side effects do to formaldyhyde reactivation. The sample of 60,000 children in Sweden with over 100,000 injections and growing every day is would have generated some side effects if they were there. That sample size is so big that on a statistical basis any problem would have already shown up. Just remember that the sample size to poll which candidate will win the presidency is only 1200 people out of 200 million voters. To reiterate, NVX has no Formaldeyde in the P part and even if SSI uses it in the D & T; SSI is able to extract it after the purification process to the point where it is inmaterial.

To: Rick Strange who wrote (175)	12/16/1997 8:56:00 AM
From: Don W Stone	Read Replies (2) \| Respond to of 507

Rick: You said : <<<<I think that you would be wise to back off of your unsubstantiated claims that formaldehyde inactivated toxoids cause side-effects>>>. I never said that formaldehyde caused side-effects. I am conveying what is presented in the NVX literture that formaldehyde is a less desirable way to inactivate the pertussis toxoid than the way NVX did with Certiva. It may be all right with D and T. Exactly why I don't know. If you are a microbiologist perhaps you could elaborate for us. From what you are saying are you implying that the Adverse Events that the others are having is perhaps due to the other components that they have added? Actually , I don't care if they all used lemon juice if it gets the desired results. Bottomline is NVX's CERTIVA is a lot safer vaccine than any of the DTaP vaccines that are now on the market. With in excess of 200,000 doses administered they have experienced ZERO Adverse Events. Tough record to beat wouldn't you say? How do you account for that?